Todd Berard is Chief Marketing Officer of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 107,407 shares of BLFS, which is worth approximately $2.84 Million. The most recent transaction as insider was on May 31, 2023, when has been sold 337 shares (Common Stock) at a price of $23.21 per share, resulting in proceeds of $7,821. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 107K
0.69% 3M change
8.22% 12M change
Total Value Held $2.84 Million

Todd Berard Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 31 2023
SELL
Open market or private sale
$7,821 $23.21 p/Share
337 Reduced 0.28%
119,448 Common Stock
May 15 2023
SELL
Open market or private sale
$1,721 $18.71 p/Share
92 Reduced 0.08%
119,785 Common Stock
Apr 06 2023
SELL
Open market or private sale
$30,946 $20.03 p/Share
1,545 Reduced 1.31%
116,267 Common Stock
Mar 29 2023
SELL
Open market or private sale
$10,743 $20.62 p/Share
521 Reduced 0.44%
117,812 Common Stock
Mar 01 2023
SELL
Open market or private sale
$19,883 $22.75 p/Share
874 Reduced 0.73%
118,333 Common Stock
Feb 09 2023
SELL
Open market or private sale
$1,426 $24.6 p/Share
58 Reduced 0.05%
119,207 Common Stock
Feb 08 2023
SELL
Open market or private sale
$226,170 $25.13 p/Share
9,000 Reduced 7.02%
119,265 Common Stock
Feb 08 2023
BUY
Exercise of conversion of derivative security
$18,540 $2.06 p/Share
9,000 Added 6.56%
128,265 Common Stock
Feb 07 2023
SELL
Open market or private sale
$25,290 $25.29 p/Share
1,000 Reduced 0.83%
119,265 Common Stock
Feb 07 2023
BUY
Exercise of conversion of derivative security
$2,060 $2.06 p/Share
1,000 Added 0.82%
120,265 Common Stock
Jan 23 2023
SELL
Open market or private sale
$87,535 $25.01 p/Share
3,500 Reduced 2.85%
119,265 Common Stock
Jan 23 2023
BUY
Exercise of conversion of derivative security
$7,210 $2.06 p/Share
3,500 Added 2.77%
122,765 Common Stock
Jan 18 2023
SELL
Open market or private sale
$162,760 $25.04 p/Share
6,500 Reduced 5.17%
119,265 Common Stock
Jan 18 2023
BUY
Exercise of conversion of derivative security
$13,390 $2.06 p/Share
6,500 Added 4.91%
125,765 Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
11,885 Added 9.06%
119,265 Common Stock
Dec 28 2022
SELL
Open market or private sale
$8,466 $16.9 p/Share
501 Reduced 0.46%
107,380 Common Stock
Nov 10 2022
SELL
Open market or private sale
$1,158 $23.16 p/Share
50 Reduced 0.05%
107,881 Common Stock
Sep 29 2022
SELL
Open market or private sale
$10,658 $23.02 p/Share
463 Reduced 0.43%
107,931 Common Stock
Aug 10 2022
SELL
Open market or private sale
$1,205 $23.17 p/Share
52 Reduced 0.05%
108,394 Common Stock
Jun 28 2022
SELL
Open market or private sale
$7,356 $14.86 p/Share
495 Reduced 0.45%
108,446 Common Stock
May 13 2022
SELL
Open market or private sale
$628 $12.32 p/Share
51 Reduced 0.05%
108,941 Common Stock
Apr 18 2022
SELL
Open market or private sale
$238,890 $17.59 p/Share
13,581 Reduced 11.08%
108,992 Common Stock
Apr 12 2022
BUY
Exercise of conversion of derivative security
-
32,136 Added 20.77%
122,573 Common Stock
Mar 29 2022
SELL
Open market or private sale
$10,564 $22.24 p/Share
475 Reduced 0.52%
90,437 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
-
14,019 Added 13.36%
90,912 Common Stock
TB

Todd Berard

Chief Marketing Officer
Bothell, WA

Track Institutional and Insider Activities on BLFS

Follow BIOLIFE SOLUTIONS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS